Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 89

Published Date: 02 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Gastrointestinal Stromal Tumor Molecular Diagnostics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

A method for diagnosing gastrointestinal Stromal Tumor
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Gastrointestinal Stromal Tumor Molecular Diagnostics industry chain, the market status of Clinical Diagnosis (PCR, FISH), Drug Screening (PCR, FISH), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gastrointestinal Stromal Tumor Molecular Diagnostics.

Regionally, the report analyzes the Gastrointestinal Stromal Tumor Molecular Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gastrointestinal Stromal Tumor Molecular Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Gastrointestinal Stromal Tumor Molecular Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gastrointestinal Stromal Tumor Molecular Diagnostics industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., PCR, FISH).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gastrointestinal Stromal Tumor Molecular Diagnostics market.

Regional Analysis: The report involves examining the Gastrointestinal Stromal Tumor Molecular Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gastrointestinal Stromal Tumor Molecular Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Gastrointestinal Stromal Tumor Molecular Diagnostics:
Company Analysis: Report covers individual Gastrointestinal Stromal Tumor Molecular Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gastrointestinal Stromal Tumor Molecular Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinical Diagnosis, Drug Screening).

Technology Analysis: Report covers specific technologies relevant to Gastrointestinal Stromal Tumor Molecular Diagnostics. It assesses the current state, advancements, and potential future developments in Gastrointestinal Stromal Tumor Molecular Diagnostics areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gastrointestinal Stromal Tumor Molecular Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Gastrointestinal Stromal Tumor Molecular Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
PCR
FISH
DNA Sequencing
Gene Chip

Market segment by Application
Clinical Diagnosis
Drug Screening
Research

Market segment by players, this report covers
Yin Feng Gene
KingMed
Geneis
Haplox
AmoyDX
Admera
GeneChem

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gastrointestinal Stromal Tumor Molecular Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gastrointestinal Stromal Tumor Molecular Diagnostics, with revenue, gross margin and global market share of Gastrointestinal Stromal Tumor Molecular Diagnostics from 2019 to 2024.
Chapter 3, the Gastrointestinal Stromal Tumor Molecular Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gastrointestinal Stromal Tumor Molecular Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastrointestinal Stromal Tumor Molecular Diagnostics.
Chapter 13, to describe Gastrointestinal Stromal Tumor Molecular Diagnostics research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gastrointestinal Stromal Tumor Molecular Diagnostics
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Gastrointestinal Stromal Tumor Molecular Diagnostics by Type
        1.3.1 Overview: Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Type in 2023
        1.3.3 PCR
        1.3.4 FISH
        1.3.5 DNA Sequencing
        1.3.6 Gene Chip
    1.4 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market by Application
        1.4.1 Overview: Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Clinical Diagnosis
        1.4.3 Drug Screening
        1.4.4 Research
    1.5 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size & Forecast
    1.6 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast by Region
        1.6.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region, (2019-2030)
        1.6.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Prospect (2019-2030)
        1.6.4 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Prospect (2019-2030)
        1.6.6 South America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Yin Feng Gene
        2.1.1 Yin Feng Gene Details
        2.1.2 Yin Feng Gene Major Business
        2.1.3 Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Product and Solutions
        2.1.4 Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Yin Feng Gene Recent Developments and Future Plans
    2.2 KingMed
        2.2.1 KingMed Details
        2.2.2 KingMed Major Business
        2.2.3 KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Product and Solutions
        2.2.4 KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 KingMed Recent Developments and Future Plans
    2.3 Geneis
        2.3.1 Geneis Details
        2.3.2 Geneis Major Business
        2.3.3 Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Product and Solutions
        2.3.4 Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Geneis Recent Developments and Future Plans
    2.4 Haplox
        2.4.1 Haplox Details
        2.4.2 Haplox Major Business
        2.4.3 Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Product and Solutions
        2.4.4 Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Haplox Recent Developments and Future Plans
    2.5 AmoyDX
        2.5.1 AmoyDX Details
        2.5.2 AmoyDX Major Business
        2.5.3 AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Product and Solutions
        2.5.4 AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 AmoyDX Recent Developments and Future Plans
    2.6 Admera
        2.6.1 Admera Details
        2.6.2 Admera Major Business
        2.6.3 Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Product and Solutions
        2.6.4 Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Admera Recent Developments and Future Plans
    2.7 GeneChem
        2.7.1 GeneChem Details
        2.7.2 GeneChem Major Business
        2.7.3 GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Product and Solutions
        2.7.4 GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 GeneChem Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Gastrointestinal Stromal Tumor Molecular Diagnostics by Company Revenue
        3.2.2 Top 3 Gastrointestinal Stromal Tumor Molecular Diagnostics Players Market Share in 2023
        3.2.3 Top 6 Gastrointestinal Stromal Tumor Molecular Diagnostics Players Market Share in 2023
    3.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Market: Overall Company Footprint Analysis
        3.3.1 Gastrointestinal Stromal Tumor Molecular Diagnostics Market: Region Footprint
        3.3.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Market: Company Product Type Footprint
        3.3.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Application (2019-2024)
    5.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type (2019-2030)
    6.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Application (2019-2030)
    6.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
        6.3.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Country (2019-2030)
        6.3.2 United States Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)
        6.3.3 Canada Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)
        6.3.4 Mexico Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type (2019-2030)
    7.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Application (2019-2030)
    7.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
        7.3.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Country (2019-2030)
        7.3.2 Germany Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)
        7.3.3 France Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)
        7.3.5 Russia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)
        7.3.6 Italy Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region
        8.3.1 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Region (2019-2030)
        8.3.2 China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)
        8.3.3 Japan Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)
        8.3.4 South Korea Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)
        8.3.5 India Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)
        8.3.7 Australia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type (2019-2030)
    9.2 South America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Application (2019-2030)
    9.3 South America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
        9.3.1 South America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Country (2019-2030)
        9.3.2 Brazil Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)
        9.3.3 Argentina Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
        10.3.1 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Country (2019-2030)
        10.3.2 Turkey Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)
        10.3.4 UAE Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Drivers
    11.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Restraints
    11.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Gastrointestinal Stromal Tumor Molecular Diagnostics Industry Chain
    12.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Upstream Analysis
    12.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Midstream Analysis
    12.4 Gastrointestinal Stromal Tumor Molecular Diagnostics Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Yin Feng Gene Company Information, Head Office, and Major Competitors
    Table 6. Yin Feng Gene Major Business
    Table 7. Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Product and Solutions
    Table 8. Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Yin Feng Gene Recent Developments and Future Plans
    Table 10. KingMed Company Information, Head Office, and Major Competitors
    Table 11. KingMed Major Business
    Table 12. KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Product and Solutions
    Table 13. KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. KingMed Recent Developments and Future Plans
    Table 15. Geneis Company Information, Head Office, and Major Competitors
    Table 16. Geneis Major Business
    Table 17. Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Product and Solutions
    Table 18. Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Geneis Recent Developments and Future Plans
    Table 20. Haplox Company Information, Head Office, and Major Competitors
    Table 21. Haplox Major Business
    Table 22. Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Product and Solutions
    Table 23. Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Haplox Recent Developments and Future Plans
    Table 25. AmoyDX Company Information, Head Office, and Major Competitors
    Table 26. AmoyDX Major Business
    Table 27. AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Product and Solutions
    Table 28. AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. AmoyDX Recent Developments and Future Plans
    Table 30. Admera Company Information, Head Office, and Major Competitors
    Table 31. Admera Major Business
    Table 32. Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Product and Solutions
    Table 33. Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Admera Recent Developments and Future Plans
    Table 35. GeneChem Company Information, Head Office, and Major Competitors
    Table 36. GeneChem Major Business
    Table 37. GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Product and Solutions
    Table 38. GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. GeneChem Recent Developments and Future Plans
    Table 40. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (USD Million) by Players (2019-2024)
    Table 41. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Share by Players (2019-2024)
    Table 42. Breakdown of Gastrointestinal Stromal Tumor Molecular Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 43. Market Position of Players in Gastrointestinal Stromal Tumor Molecular Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 44. Head Office of Key Gastrointestinal Stromal Tumor Molecular Diagnostics Players
    Table 45. Gastrointestinal Stromal Tumor Molecular Diagnostics Market: Company Product Type Footprint
    Table 46. Gastrointestinal Stromal Tumor Molecular Diagnostics Market: Company Product Application Footprint
    Table 47. Gastrointestinal Stromal Tumor Molecular Diagnostics New Market Entrants and Barriers to Market Entry
    Table 48. Gastrointestinal Stromal Tumor Molecular Diagnostics Mergers, Acquisition, Agreements, and Collaborations
    Table 49. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (USD Million) by Type (2019-2024)
    Table 50. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Share by Type (2019-2024)
    Table 51. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Forecast by Type (2025-2030)
    Table 52. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Application (2019-2024)
    Table 53. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Forecast by Application (2025-2030)
    Table 54. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 55. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 56. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 57. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 58. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
    Table 59. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
    Table 60. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 61. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 62. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 63. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 64. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
    Table 65. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
    Table 66. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 67. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 68. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 69. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 70. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
    Table 71. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
    Table 72. South America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 73. South America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 74. South America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 75. South America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 76. South America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
    Table 77. South America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
    Table 78. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
    Table 79. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
    Table 80. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
    Table 81. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
    Table 82. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
    Table 83. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
    Table 84. Gastrointestinal Stromal Tumor Molecular Diagnostics Raw Material
    Table 85. Key Suppliers of Gastrointestinal Stromal Tumor Molecular Diagnostics Raw Materials
List of Figures
    Figure 1. Gastrointestinal Stromal Tumor Molecular Diagnostics Picture
    Figure 2. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Type in 2023
    Figure 4. PCR
    Figure 5. FISH
    Figure 6. DNA Sequencing
    Figure 7. Gene Chip
    Figure 8. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 9. Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Application in 2023
    Figure 10. Clinical Diagnosis Picture
    Figure 11. Drug Screening Picture
    Figure 12. Research Picture
    Figure 13. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Market Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 16. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Region (2019-2030)
    Figure 17. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Region in 2023
    Figure 18. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 20. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 21. South America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 22. Middle East and Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 23. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Share by Players in 2023
    Figure 24. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 25. Global Top 3 Players Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share in 2023
    Figure 26. Global Top 6 Players Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share in 2023
    Figure 27. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Share by Type (2019-2024)
    Figure 28. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share Forecast by Type (2025-2030)
    Figure 29. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Share by Application (2019-2024)
    Figure 30. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share Forecast by Application (2025-2030)
    Figure 31. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 32. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 33. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Country (2019-2030)
    Figure 34. United States Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 35. Canada Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 36. Mexico Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 37. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 38. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 39. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Country (2019-2030)
    Figure 40. Germany Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 41. France Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 42. United Kingdom Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 43. Russia Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 44. Italy Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 45. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 46. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 47. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Region (2019-2030)
    Figure 48. China Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 49. Japan Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 50. South Korea Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 51. India Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 52. Southeast Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 53. Australia Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 54. South America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 55. South America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 56. South America Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Country (2019-2030)
    Figure 57. Brazil Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 58. Argentina Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 59. Middle East and Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Type (2019-2030)
    Figure 60. Middle East and Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Application (2019-2030)
    Figure 61. Middle East and Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value Market Share by Country (2019-2030)
    Figure 62. Turkey Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 63. Saudi Arabia Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 64. UAE Gastrointestinal Stromal Tumor Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
    Figure 65. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Drivers
    Figure 66. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Restraints
    Figure 67. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor Molecular Diagnostics in 2023
    Figure 70. Manufacturing Process Analysis of Gastrointestinal Stromal Tumor Molecular Diagnostics
    Figure 71. Gastrointestinal Stromal Tumor Molecular Diagnostics Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Yin Feng Gene
KingMed
Geneis
Haplox
AmoyDX
Admera
GeneChem

Related Reports

Global Gastrointestinal Stromal Tumor Molecular Diagnostics Supply, Demand and Key Producers, 2023-2029

Global Gastrointestinal Stromal Tumor Molecular Diagnostics Supply, Demand and Key Producers, 2023-2029

date 20 Jan 2023

date Medical Care

The global Gastrointestinal Stromal Tumor Molecular Diagnostics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Product Tags

Gastrointestinal Stromal Tumor Molecular Diagnostics

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>